IPO
-
-
-
-
-
-
-
Kaleido Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Kaleido Biosciences Announces Upcoming Presentations at the Society for Inherited Metabolic Disorders Annual Meeting and The International Liver Congress™ (EASL)
-
-
-
-
-
-
-
Kaleido Biosciences Announces Closing of Initial Public Offering
-
-
-
-
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

